Oxytocin vs carbetocin for the prevention of postpartum hemorrhage in high risk patients

Case control study of oxytocin vs carbetocin in the prevention of postpartum hemorrhage in High risk patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060324

Enrollment

Registered

2023-11-29

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: -

Interventions

Intervention1: CARBETOCIN: Injection CARBETOCIN 100mcg/mL IV in 10 mL NS I.V over 2 minutes Control Intervention1: OXYTOCIN: Injection OXYTOCIN 10 Units Intamuscularly Stat dose

Eligibility

Inclusion criteria

Inclusion criteria: Patients having high risk for postpartum hemorrhage according to risk assessment score

Exclusion criteria

Exclusion criteria: no exclusion criteria

Design outcomes

Primary

Measure	Time frame
1) assess the uterine tone( if contracted or atonic) 2) See for amount of Blood loss Timepoint: After the delivery of the baby till one hour	—

Secondary

Measure	Time frame
1) See for pulse rate post delivery 2) see for Blood pressure post deliveryTimepoint: After the delivery of Baby to one hour postpartum	—

Countries

India

Contacts

Public ContactDr Vaishnavi Watane

MGM MCH Aurangabad

mandeshubhangi6@gmail.com9284389631

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026